130 related articles for article (PubMed ID: 31246553)
41. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
42. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
43. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
[TBL] [Abstract][Full Text] [Related]
44. Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya.
Adewumi K; Oketch SY; Choi Y; Huchko MJ
BMC Womens Health; 2019 Aug; 19(1):107. PubMed ID: 31395060
[TBL] [Abstract][Full Text] [Related]
45. Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda.
Mitchell S; Ogilvie G; Steinberg M; Sekikubo M; Biryabarema C; Money D
Int J Gynaecol Obstet; 2011 Aug; 114(2):111-5. PubMed ID: 21669428
[TBL] [Abstract][Full Text] [Related]
46. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
47. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
Holt HK; Zhang L; Zhao FH; Hu SY; Zhao XL; Zhang X; Pan QJ; Zhang WH; Smith JS; Qiao YL
Int J Cancer; 2017 Feb; 140(3):544-554. PubMed ID: 27727464
[TBL] [Abstract][Full Text] [Related]
49. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South Africa.
Mahomed K; Evans D; Sauls C; Richter K; Smith J; Firnhaber C
Pan Afr Med J; 2014; 17():189. PubMed ID: 25396015
[TBL] [Abstract][Full Text] [Related]
51. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
52. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
[TBL] [Abstract][Full Text] [Related]
53. Saudi Women's Knowledge and Attitude toward Cervical Cancer Screening, Treatment, and Prevention: A Cross-Sectional Study in Qassim Region (2018-2019).
Alnafisah RA; Alsuhaibani R; Alharbi MA; Alsohaibani AA; Ismail AA
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2965-2969. PubMed ID: 31653142
[TBL] [Abstract][Full Text] [Related]
54. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
[TBL] [Abstract][Full Text] [Related]
55. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
56. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
[TBL] [Abstract][Full Text] [Related]
57. A Qualitative Exploration of Barriers to Treatment Among HPV-Positive Women in a Cervical Cancer Screening Study in Western Kenya.
Isaacson S; Adewumi K; Smith JS; Novak C; Oketch S; Huchko MJ
Oncologist; 2023 Jan; 28(1):e9-e18. PubMed ID: 36239434
[TBL] [Abstract][Full Text] [Related]
58. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Ogilvie GS; Smith LW; van Niekerk DJ; Khurshed F; Krajden M; Saraiya M; Goel V; Rimer BK; Greene SB; Hobbs S; Coldman AJ; Franco EL
Int J Cancer; 2013 Dec; 133(12):2934-43. PubMed ID: 23754203
[TBL] [Abstract][Full Text] [Related]
59. Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies.
Page CM; Ibrahim S; Park LP; Huchko MJ
PLoS One; 2020; 15(7):e0235264. PubMed ID: 32658921
[TBL] [Abstract][Full Text] [Related]
60. Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya.
Orang'o EO; Wachira J; Asirwa FC; Busakhala N; Naanyu V; Kisuya J; Otieno G; Keter A; Mwangi A; Inui T
PLoS One; 2016; 11(6):e0157217. PubMed ID: 27310005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
